These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 9142111)

  • 1. A sensitive defense: salt and cystic fibrosis.
    Wine JJ
    Nat Med; 1997 May; 3(5):494-5. PubMed ID: 9142111
    [No Abstract]   [Full Text] [Related]  

  • 2. Is cystic fibrosis lung disease caused by abnormal ion composition or abnormal volume?
    Krouse ME
    J Gen Physiol; 2001 Aug; 118(2):219-22. PubMed ID: 11479348
    [No Abstract]   [Full Text] [Related]  

  • 3. Unravelling salt transport in cystic fibrosis.
    Noone PG; Southern KW
    Thorax; 2004 Nov; 59(11):916-7. PubMed ID: 15516460
    [No Abstract]   [Full Text] [Related]  

  • 4. Cystic fibrosis and the salt controversy.
    Guggino WB
    Cell; 1999 Mar; 96(5):607-10. PubMed ID: 10089875
    [No Abstract]   [Full Text] [Related]  

  • 5. Salt-independent abnormality of antimicrobial activity in cystic fibrosis airway surface fluid.
    Bals R; Weiner DJ; Meegalla RL; Accurso F; Wilson JM
    Am J Respir Cell Mol Biol; 2001 Jul; 25(1):21-5. PubMed ID: 11472971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [A simple method for detecting increased salt excretion in sweat].
    STOPPELMAN MR
    Maandschr Kindergeneeskd; 1957 Apr; 25(4):109-11. PubMed ID: 13440142
    [No Abstract]   [Full Text] [Related]  

  • 7. Cystic fibrosis.
    Rowe SM; Miller S; Sorscher EJ
    N Engl J Med; 2005 May; 352(19):1992-2001. PubMed ID: 15888700
    [No Abstract]   [Full Text] [Related]  

  • 8. Altered NaCl concentration of airway surface liquid in cystic fibrosis.
    Widdicombe JH
    Pflugers Arch; 2001; 443 Suppl 1():S8-10. PubMed ID: 11845295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Aldosterone effect on the sodium chloride and potassium excretion in the sweat of cystic fibrosis patients and healthy persons].
    Emrich HM; Stoll E; Rossi E
    Klin Wochenschr; 1970 Aug; 48(16):966-72. PubMed ID: 5519411
    [No Abstract]   [Full Text] [Related]  

  • 10. Manipulation of volume vs osmolality in cystic fibrosis lung disease.
    Teramoto S; Mastsue T; Ouchi Y
    Chest; 1999 Nov; 116(5):1494-5. PubMed ID: 10559127
    [No Abstract]   [Full Text] [Related]  

  • 11. Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis.
    Goldman MJ; Anderson GM; Stolzenberg ED; Kari UP; Zasloff M; Wilson JM
    Cell; 1997 Feb; 88(4):553-60. PubMed ID: 9038346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic modulation of salt and water in the airway epithelium in cystic fibrosis.
    Knowles MR; Olivier K; Noone P; Boucher RC
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S65-9. PubMed ID: 7533608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does extensive genotyping and nasal potential difference testing clarify the diagnosis of cystic fibrosis among patients with single-organ manifestations of cystic fibrosis?
    Ooi CY; Dupuis A; Ellis L; Jarvi K; Martin S; Ray PN; Steele L; Kortan P; Gonska T; Dorfman R; Solomon M; Zielenski J; Corey M; Tullis E; Durie P
    Thorax; 2014 Mar; 69(3):254-60. PubMed ID: 24149827
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electrolyte transport in exocrine human sweat glands].
    Emrich HM; Friolet B; Stoll E; Rossi E
    Bull Schweiz Akad Med Wiss; 1967 Dec; 23(3):376-83. PubMed ID: 5596399
    [No Abstract]   [Full Text] [Related]  

  • 15. Sweat composition in relation to rate of sweating in patients with cystic fibrosis of the pancreas.
    Emrich HM; Stoll E; Friolet B; Colombo JP; Richterich R; Rossi E
    Pediatr Res; 1968 Nov; 2(6):464-78. PubMed ID: 5727917
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimicrobial peptide therapeutics for cystic fibrosis.
    Zhang L; Parente J; Harris SM; Woods DE; Hancock RE; Falla TJ
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2921-7. PubMed ID: 15980369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of tobramycin in cystic fibrosis.
    Kelly HB; Menendez R; Fan L; Murphy S
    J Pediatr; 1982 Feb; 100(2):318-21. PubMed ID: 7057342
    [No Abstract]   [Full Text] [Related]  

  • 18. Salt, chloride, bleach, and innate host defense.
    Wang G; Nauseef WM
    J Leukoc Biol; 2015 Aug; 98(2):163-72. PubMed ID: 26048979
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Salt depletion syndrome as the initial presentation of cystic fibrosis in a toddler with the rare p.Ala309Gly (A309G) CFTR variant.
    Salvatore D; Dell'Edera D; Colangelo C; Smaldore G
    Clin Genet; 2016 Aug; 90(2):186-7. PubMed ID: 26856987
    [No Abstract]   [Full Text] [Related]  

  • 20. Deficient hydrophilic lung surfactant proteins A and D with normal surfactant phospholipid molecular species in cystic fibrosis.
    Postle AD; Mander A; Reid KB; Wang JY; Wright SM; Moustaki M; Warner JO
    Am J Respir Cell Mol Biol; 1999 Jan; 20(1):90-8. PubMed ID: 9870921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.